Developer docs
API playgroundTry for free, no card

Search company profiles

Sarcoma Alliance

Full company profile

uuid000qpsn

Namestring
Sarcoma Alliance
Legal namestring
Sarcoma Alliance
Company typeenum
Private
Founded yearint
1999
Descriptiontext

The Sarcoma Alliance is a 501(c)(3) nonprofit founded in 1999 by Suzanne Leider and headquartered in Mill Valley, California. It provides guidance, education, and support to sarcoma patients and their families, offering all services free of charge and funded entirely by donations. Its core programs include Second Opinion Grants (direct financial assistance to patients seeking specialist consultations), the annual Sarcoma Exchange conference, peer support groups, a New Patient Guide, a Sarcoma Centers Database, educational webinars, financial assistance, a wellness blog, and an e-newsletter. The organization also operates a Medical Advisory Board comprising leading sarcoma oncologists, lending clinical credibility to its educational content.

The Sarcoma Alliance operates with a small team of 1-10 employees and an international scope, distributing content through digital channels to reach patients globally. Its addressable population is approximately 17,000 sarcoma diagnoses annually in the US, with international expansion beyond US borders. The business model is donation-driven: there are no fees charged for services, and revenue is generated through individual donations, corporate sponsorships, and partnerships. Major partners include Wendy Walk (a core partnership channeling funds through the Leslie Schimel Memorial Grants), SpringWorks Therapeutics, ONEHOPE Wine, Imerman Angels, CAREasy, the Cancer Support Community of Redondo Beach, the Children's Hospital of Philadelphia (CHOP), and the EHE Foundation, plus six pharmaceutical sponsors of the 2026 Sarcoma Exchange.

The organization's strategic posture is one of incremental programmatic expansion: launching subtype-specific conferences (Synovial Sarcoma with CHOP in 2025; EHE 360 with the EHE Foundation in 2025), scaling the flagship Sarcoma Exchange to its 9th annual edition in 2026, and expanding the Second Opinion Grant Program. Board leadership is anchored by founder-family continuity through President Philip Leider, with governance supported by VP Natasha Serrano, Treasurer Michael Rhine, and Secretary Jeffrey Coyne.

Short descriptiontext

The Sarcoma Alliance is a 501(c)(3) nonprofit founded in 1999 that provides free guidance, education, and support to sarcoma patients and their families through grants, conferences, support groups, and digital resources, funded entirely by donations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMill Valley, United States
HQ citystring
Mill Valley
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
sarcoma patient advocacy, cancer support services, rare cancer nonprofit, patient education resources, second opinion grants
Industry1 code
1Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryYes
NAICS code3 codes
  • Other Individual and Family Services624190
  • Social Advocacy Organizations8133
  • Social Assistance624
SIC code3 codes
  • Services-Social Services8300
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Educational Services8200
Product category
Patient Advocacy and Cancer Support Services
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Sarcoma Alliance is a 501(c)(3) public charity that provides free, direct support services to people affected by sarcoma. Its core offerings include one-on-one peer guidance from trained mentors, Second Opinion Grants that reimburse patients for sarcoma-specialist consultations, moderated online support groups, and the Sarcoma Exchange educational resource library, supplemented by community events such as the annual Steps to Cure Sarcoma walk.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Free services to all sarcoma patients
+3 more records
Product overview1 text field

Sarcoma Alliance operates as a single unified nonprofit service offering, not a technology platform. The organization provides a portfolio of patient support services centered around its core mission: guidance, education, and support for sarcoma patients and families. Key offerings include the Second Opinion Grants program (Suzanne Renée Leider Memorial Assistance Fund), the annual Sarcoma Exchange educational symposium, support groups, a New Patient Guide, a sarcoma centers database, educational webinars and resources, financial assistance programs, and a wellness blog. The organization also sells merchandise (ribbon pins, apparel) through its shop to raise awareness and funds. All services are provided free of charge to patients.

Product and service1 record
1Second Opinion Grants
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierMinorTypeGTM or Marketing Partner
Description

Partnership with ONEHOPE Wine and entrepreneur Jessica Pajak. For each wine purchase, 10% is donated to the Sarcoma Alliance—and the Pajak family matches that amount. Emma Pajak, daughter of Jessica, is an Ewing sarcoma survivor. This ongoing partnership supports sarcoma awareness through wine sales.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership connecting sarcoma patients with Mentor Angels—someone who has survived the same type of cancer. Patients can sign up to receive one-to-one support from trained volunteer survivors.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ongoing partnership with Wendy Walk, founded by the children of sarcoma patient Wendy who died in 2013. Wendy Walk hosts annual fundraising walks and has raised over $4 million for sarcoma research. Through this partnership, the Leslie Schimel Memorial Grants provide second medical opinions for sarcoma patients. The organizations co-host the annual Wendy Walk event.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Pharmaceutical company sponsor of free webinars on desmoid tumors. Partnership focused on patient education about desmoid tumor diagnosis, treatment, and survivorship.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Vehicle donation partner allowing donors to contribute cars, trucks, or other vehicles. The organization handles pickup anywhere in the USA (and parts of Canada), sells the vehicle, and donates proceeds to the Sarcoma Alliance. Phone: 855-500-RIDE.

6Cancer Support Community of Redondo Beach
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Partnership for the Sarcoma Alliance Networking Group, a free drop-in support group for newly diagnosed sarcoma patients, those in treatment, survivors, caregivers, and family members. Facilitated by Jill Gray, MA, LMFT.

sarcomaalliance.org
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-host of the Inaugural 2025 Synovial Sarcoma Virtual Conference on March 1, 2025, in partnership with the Sarcoma Alliance.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Co-host of the 2025 Epithelioid Hemangioendothelioma (EHE) 360 Global Patient Conference (April 10-11, 2025). The EHE Foundation organizes the largest annual gathering of EHE patients, clinicians, and researchers, with participants from 25+ countries.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large umbrella rare-disease advocacy organization serving patients across 7,000+ rare conditions. Comparable in rare-disease patient advocacy, education, and policy work though broader scope and much larger scale.

TypeDirect peer
Description

Epithelioid hemangioendothelioma patient organization and active Sarcoma Alliance partner. Directly comparable in subtype-focused patient advocacy, conferences, and small-team operation.

TypeBroad incumbent
Description

Large national nonprofit offering support groups and educational resources to all cancer patients. Comparable in delivering free psychosocial support and education, though across all cancer types with much larger infrastructure.

4Wendy Walk
TypeDirect peer
Description

Fundraising-focused sarcoma nonprofit and Sarcoma Alliance's core strategic partner that has raised over $4M for sarcoma research. Comparable disease focus with a fundraising/events-led model.

TypeEmerging player
Description

Cancer 1:1 peer support organization and Sarcoma Alliance partner. Directly comparable in providing free survivor-mentor matching for cancer patients, though broader across cancer types.

TypeBroad incumbent
Description

Major pediatric cancer research and treatment consortium that serves ~15% of sarcoma patients in the pediatric population. Comparable in addressing pediatric sarcoma specifically with a clinical/research focus rather than patient guidance.

TypeDirect peer
Description

The largest US sarcoma nonprofit, focused primarily on research funding and advocacy. Directly comparable disease focus and patient community, though focused on research rather than guidance/support services.

TypeBroad incumbent
Description

Large cancer survivorship organization providing patient navigation, education, and support. Comparable in mission emphasis on survivorship and patient support, though broader scope and substantially larger budget.

TypeDirect peer
Description

Sarcoma subtype-specific patient advocacy and research organization serving LMS patients. Directly comparable in disease focus, patient support mission, and small nonprofit structure.

TypeBroad incumbent
Description

Largest US cancer nonprofit providing research, patient support, and education across all cancer types. Competes for the same donor dollars and offers overlapping patient navigation services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sarcoma Alliance

Patient Advocacy and Cancer Support Servicessarcomaalliance.org

The Sarcoma Alliance is a 501(c)(3) nonprofit founded in 1999 that provides free guidance, education, and support to sarcoma patients and their families through grants, conferences, support groups, and digital resources, funded entirely by donations.

What Sarcoma Alliance does

The Sarcoma Alliance is a 501(c)(3) nonprofit founded in 1999 by Suzanne Leider and headquartered in Mill Valley, California. It provides guidance, education, and support to sarcoma patients and their families, offering all services free of charge and funded entirely by donations. Its core programs include Second Opinion Grants (direct financial assistance to patients seeking specialist consultations), the annual Sarcoma Exchange conference, peer support groups, a New Patient Guide, a Sarcoma Centers Database, educational webinars, financial assistance, a wellness blog, and an e-newsletter. The organization also operates a Medical Advisory Board comprising leading sarcoma oncologists, lending clinical credibility to its educational content.

The Sarcoma Alliance operates with a small team of 1-10 employees and an international scope, distributing content through digital channels to reach patients globally. Its addressable population is approximately 17,000 sarcoma diagnoses annually in the US, with international expansion beyond US borders. The business model is donation-driven: there are no fees charged for services, and revenue is generated through individual donations, corporate sponsorships, and partnerships. Major partners include Wendy Walk (a core partnership channeling funds through the Leslie Schimel Memorial Grants), SpringWorks Therapeutics, ONEHOPE Wine, Imerman Angels, CAREasy, the Cancer Support Community of Redondo Beach, the Children's Hospital of Philadelphia (CHOP), and the EHE Foundation, plus six pharmaceutical sponsors of the 2026 Sarcoma Exchange.

The organization's strategic posture is one of incremental programmatic expansion: launching subtype-specific conferences (Synovial Sarcoma with CHOP in 2025; EHE 360 with the EHE Foundation in 2025), scaling the flagship Sarcoma Exchange to its 9th annual edition in 2026, and expanding the Second Opinion Grant Program. Board leadership is anchored by founder-family continuity through President Philip Leider, with governance supported by VP Natasha Serrano, Treasurer Michael Rhine, and Secretary Jeffrey Coyne.

Sarcoma Alliance firmographics

Firmographics
Name
Sarcoma Alliance
Legal name
Sarcoma Alliance
Website
https://sarcomaalliance.org
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1–10 employees
Short description
The Sarcoma Alliance is a 501(c)(3) nonprofit founded in 1999 that provides free guidance, education, and support to sarcoma patients and their families through grants, conferences, support groups, and digital resources, funded entirely by donations.
Ownership category
akta.pro rank

Sarcoma Alliance industry classification

Industry
Product category
Patient Advocacy and Cancer Support Services
NAICS
Other Individual and Family Services (624190), Social Advocacy Organizations (8133), Social Assistance (624)
SIC
Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090), Services-Educational Services (8200)
akta.pro primary industry
Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

  • Sarcoma patient advocacy
  • Cancer support services
  • Rare cancer nonprofit
  • Patient education resources
  • Second opinion grants

Where Sarcoma Alliance is headquartered

Location

Headquarters

HQ city
Mill Valley
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Sarcoma Alliance business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Distribution channels4 records

Marketing channels8 records

Sarcoma Alliance product offering

Product offering

Core offering

Sarcoma Alliance is a 501(c)(3) public charity that provides free, direct support services to people affected by sarcoma. Its core offerings include one-on-one peer guidance from trained mentors, Second Opinion Grants that reimburse patients for sarcoma-specialist consultations, moderated online support groups, and the Sarcoma Exchange educational resource library, supplemented by community events such as the annual Steps to Cure Sarcoma walk.

Product overview

Sarcoma Alliance operates as a single unified nonprofit service offering, not a technology platform. The organization provides a portfolio of patient support services centered around its core mission: guidance, education, and support for sarcoma patients and families. Key offerings include the Second Opinion Grants program (Suzanne Renée Leider Memorial Assistance Fund), the annual Sarcoma Exchange educational symposium, support groups, a New Patient Guide, a sarcoma centers database, educational webinars and resources, financial assistance programs, and a wellness blog. The organization also sells merchandise (ribbon pins, apparel) through its shop to raise awareness and funds. All services are provided free of charge to patients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Second Opinion Grants

Quantifiable outcome

  • Free services to all sarcoma patients
  • +3 more outcomes

Companies that use Sarcoma Alliance

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Sarcoma Alliance technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Sarcoma Alliance partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered minor and core.

  • ONEHOPE WineminorGTM or Marketing PartnerPartnership with ONEHOPE Wine and entrepreneur Jessica Pajak. For each wine purchase, 10% is donated to the Sarcoma Alliance—and the Pajak family matches that amount. Emma Pajak, daughter of Jessica, is an Ewing sarcoma survivor. This ongoing partnership supports sarcoma awareness through wine sales.
  • Imerman AngelsminorStrategic or Co-development PartnerPartnership connecting sarcoma patients with Mentor Angels—someone who has survived the same type of cancer. Patients can sign up to receive one-to-one support from trained volunteer survivors.
  • Wendy WalkcoreStrategic or Co-development PartnerOngoing partnership with Wendy Walk, founded by the children of sarcoma patient Wendy who died in 2013. Wendy Walk hosts annual fundraising walks and has raised over $4 million for sarcoma research. Through this partnership, the Leslie Schimel Memorial Grants provide second medical opinions for sarcoma patients. The organizations co-host the annual Wendy Walk event.
  • SpringWorks TherapeuticsminorGTM or Marketing PartnerPharmaceutical company sponsor of free webinars on desmoid tumors. Partnership focused on patient education about desmoid tumor diagnosis, treatment, and survivorship.
  • Charitable Auto Resources Inc (CAREasy)minorChannel Partner/ Reseller/ DistributorVehicle donation partner allowing donors to contribute cars, trucks, or other vehicles. The organization handles pickup anywhere in the USA (and parts of Canada), sells the vehicle, and donates proceeds to the Sarcoma Alliance. Phone: 855-500-RIDE.
  • Cancer Support Community of Redondo BeachminorStrategic or Co-development PartnerPartnership for the Sarcoma Alliance Networking Group, a free drop-in support group for newly diagnosed sarcoma patients, those in treatment, survivors, caregivers, and family members. Facilitated by Jill Gray, MA, LMFT.
  • Children's Hospital of Philadelphia (CHOP)minorStrategic or Co-development PartnerCo-host of the Inaugural 2025 Synovial Sarcoma Virtual Conference on March 1, 2025, in partnership with the Sarcoma Alliance.
  • EHE FoundationminorStrategic or Co-development PartnerCo-host of the 2025 Epithelioid Hemangioendothelioma (EHE) 360 Global Patient Conference (April 10-11, 2025). The EHE Foundation organizes the largest annual gathering of EHE patients, clinicians, and researchers, with participants from 25+ countries.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Sarcoma Alliance competitors and assessment

Company assessment

Broad incumbents

  • National Organization for Rare Disorders (NORD): Large umbrella rare-disease advocacy organization serving patients across 7,000+ rare conditions. Comparable in rare-disease patient advocacy, education, and policy work though broader scope and much larger scale.
  • Cancer Support Community: Large national nonprofit offering support groups and educational resources to all cancer patients. Comparable in delivering free psychosocial support and education, though across all cancer types with much larger infrastructure.
  • Children's Oncology Group: Major pediatric cancer research and treatment consortium that serves ~15% of sarcoma patients in the pediatric population. Comparable in addressing pediatric sarcoma specifically with a clinical/research focus rather than patient guidance.
  • Livestrong Foundation: Large cancer survivorship organization providing patient navigation, education, and support. Comparable in mission emphasis on survivorship and patient support, though broader scope and substantially larger budget.
  • American Cancer Society: Largest US cancer nonprofit providing research, patient support, and education across all cancer types. Competes for the same donor dollars and offers overlapping patient navigation services.

Direct peers

  • EHE Foundation: Epithelioid hemangioendothelioma patient organization and active Sarcoma Alliance partner. Directly comparable in subtype-focused patient advocacy, conferences, and small-team operation.
  • Wendy Walk: Fundraising-focused sarcoma nonprofit and Sarcoma Alliance's core strategic partner that has raised over $4M for sarcoma research. Comparable disease focus with a fundraising/events-led model.
  • Sarcoma Foundation of America: The largest US sarcoma nonprofit, focused primarily on research funding and advocacy. Directly comparable disease focus and patient community, though focused on research rather than guidance/support services.
  • Leiomyosarcoma (LMS) Foundation: Sarcoma subtype-specific patient advocacy and research organization serving LMS patients. Directly comparable in disease focus, patient support mission, and small nonprofit structure.

Emerging players

  • Imerman Angels: Cancer 1:1 peer support organization and Sarcoma Alliance partner. Directly comparable in providing free survivor-mentor matching for cancer patients, though broader across cancer types.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Sarcoma Alliance social profiles

Digital presence

Sarcoma Alliance financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sarcoma Alliance leadership team

Management profile

Number of profiles

Profiles6 records

Sarcoma Alliance funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sarcoma Alliance M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sarcoma Alliance

What does Sarcoma Alliance do?

Sarcoma Alliance is a 501(c)(3) public charity that provides free, direct support services to people affected by sarcoma. Its core offerings include one-on-one peer guidance from trained mentors, Second Opinion Grants that reimburse patients for sarcoma-specialist consultations, moderated online support groups, and the Sarcoma Exchange educational resource library, supplemented by community events such as the annual Steps to Cure Sarcoma walk.

Is Sarcoma Alliance a public or private company?

Sarcoma Alliance is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Sarcoma Alliance founded?

Sarcoma Alliance was founded in 1999. It employs 1 to 10 people.

Where is Sarcoma Alliance based?

Sarcoma Alliance is headquartered in Mill Valley, United States, in the North America region.

Who are Sarcoma Alliance's main competitors?

Broad incumbents on record are National Organization for Rare Disorders (NORD), Cancer Support Community, Children's Oncology Group, Livestrong Foundation and American Cancer Society. Direct peers are EHE Foundation, Wendy Walk, Sarcoma Foundation of America and Leiomyosarcoma (LMS) Foundation. Imerman Angels is listed as an emerging player.

Does Sarcoma Alliance have an API?

No public API is recorded for Sarcoma Alliance.

What industry is Sarcoma Alliance in?

Sarcoma Alliance's product category is Patient Advocacy and Cancer Support Services. Its primary akta.pro industry code is HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 624190 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales